Although, reports suggest that GM-CSF drives M1 activation in vitro (Brocheriou et al., 2011; Lacey et al., 2012; Fleetwood et al., 2007), it has recently been found to be critically important for M2 Mφ activation during kidney injury (Huen et al., 2015). The gene discussed is CSF2; the disease is injury.